Effect of Patient Education on Reducing Medication in Spinal Cord Injury Patients With Neuropathic Pain
TL;DR: It is implied that an educational pain management program, can be a valuable complement to the treatment of spinal cord injured patients with neuropathic pain, to prevent patients from developing chronic SCI-related pain.
read more
Abstract: OBJECTIVE To determine whether providing education about the disease pathophysiology and drug mechanisms and side effects, would be effective for reducing the use of pain medication while appropriately managing neurogenic pain in spinal cord injury (SCI) patients. METHODS In this prospective study, 109 patients with an SCI and neuropathic pain, participated in an educational pain management program. This comprehensive program was specifically created, for patients with an SCI and neuropathic pain. It consisted of 6 sessions, including educational training, over a 6-week period. RESULTS Of 109 patients, 79 (72.5%) initially took more than two types of pain medication, and this decreased to 36 (33.0%) after the educational pain management program was completed. The mean pain scale score and the number of pain medications decreased, compared to the baseline values. Compared to the non-response group, the response group had a shorter duration of pain onset (p=0.004), and a higher initial number of different medications (p<0.001) and certain types of medications. CONCLUSION This study results imply that an educational pain management program, can be a valuable complement to the treatment of spinal cord injured patients with neuropathic pain. Early intervention is important, to prevent patients from developing chronic SCI-related pain.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Subgroup Perspectives on Chronic Pain and Its Management After Spinal Cord Injury.
Eva Widerström-Noga,Eva Widerström-Noga,Kim D. Anderson,Salome Perez,Alberto Martinez-Arizala,Jessica M. Cambridge +5 more
TL;DR: It is suggested that treatment approaches need to be individually tailored not only to type of pain, but also to personal factors and preferences, and patients' personal preferences may provide additional tailoring options for patient-centered treatments.
9
Aging with spinal cord injury: A narrative review of consequences and challenges
Gabriel Guízar-Sahagún,Israel Grijalva,Rebecca E. Franco-Bourland,I. Madrazo +3 more
TL;DR: An updated overview of the consequences of aging withSCI is provided, highlighting the main challenges facing this population in a narrative review of the current literature retrieved from the PubMed database from 2000 to 2022 on any aspect related to aging in persons with SCI.
7
Spinal cord injury/dysfunction and medication management: a qualitative study exploring the experiences of community-dwelling adults in Ontario, Canada.
Lauren Cadel,Sander L Hitzig,Sander L Hitzig,Tanya Packer,Tejal Patel,Tejal Patel,Aisha Lofters,Aisha Lofters,Alison Thompson,Sara J T Guilcher +9 more
TL;DR: This study explores the attitudes, beliefs and experiences pertaining to the management of prescribed and unprescribed medications among community-dwelling adults with spinal cord injury/dysfunction (SCI/D) in Ontario, Canada.
4
References
American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults
TL;DR: This update has much strength, including the use of an evidence-based approach using the Institute of Medicine standards and the development of a partnership to regularly update the Criteria.
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Nadine Attal,Giorgio Cruccu,Ralf Baron,Maija Haanpää,Per Hansson,Troels S. Jensen,Turo Nurmikko +6 more
TL;DR: The second European Federation of Neurological Societies Task Force as discussed by the authors aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005, and identified studies using the Cochrane Database and Medline.
1.7K
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
TL;DR: A better understanding of neuropathic pain and of the translation of pathophysiological mechanisms into sensory signs will lead to a more effective and specific mechanism-based treatment approach.
Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
Robert H. Dworkin,Alec B. O'Connor,Joseph Audette,Ralf Baron,Geoffrey K. Gourlay,Maija Haanpää,Joel L. Kent,Elliot J. Krane,Elliot J. Krane,Alyssa Lebel,Robert M. Levy,Sean Mackey,John M. Mayer,Christine Miaskowski,Srinivasa N. Raja,Andrew S.C. Rice,Kenneth E. Schmader,Brett R. Stacey,Steven P. Stanos,Rolf-Detlef Treede,Dennis C. Turk,Gary A. Walco,Christopher D. Wells +22 more
- 01 Mar 2010
TL;DR: A review of the evidence-based guidelines for the pharmacological treatment of neuropathic pain can be found in this article, where botulinum toxin, high-concentration capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies are presented.
Neuropathic pain: An updated grading system for research and clinical practice
Nanna B. Finnerup,Simon Haroutounian,Peter R. Kamerman,Ralf Baron,David L.H. Bennett,Didier Bouhassira,Giorgio Cruccu,Roy Freeman,Per Hansson,Turo Nurmikko,Srinivasa N. Raja,Andrew S.C. Rice,Andrew S.C. Rice,Jordi Serra,Blair H. Smith,Rolf-Detlef Treede,Troels S. Jensen +16 more
TL;DR: A revised grading system of possible, probable, and definite neuropathic pain from 2008 is presented with an adjusted order, better reflecting clinical practice, improvements in the specifications, and a word of caution that even the “definite” level of neuropathicPain does not always indicate causality.